Sugi Predict

Sugi Predict / Compounds / SCHEMBL993439

SCHEMBL993439

SCHEMBL993439

COC(=O)[C@H](CO)NC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ THRB P10828 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ MDM4 O15151 1/20 0.44
▸ MDM2 Q00987 1/20 0.44
▸ KMT2A Q03164 3/20 0.43
▸ KCNN4 O15554 1/20 0.43
▸ KIF11 P52732 1/20 0.43
▸ ATM Q13315 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ NR1H2 P55055 1/20 0.40
▸ NR1H3 Q13133 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ NOS3 P29474 1/20 0.38
▸ NOS1 P29475 1/20 0.38
▸ NOS2 P35228 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL993145 1.00 ALDH1A1 (0.47) ALDH1A1CYP2C9THRBCYP2C19HSD17B10
SCHEMBL346218 1.00 ALDH1A1 (0.47) ALDH1A1CYP2C9THRBCYP2C19HSD17B10
SCHEMBL12226100 0.88 MMP8 (0.43) ALDH1A1KMT2AKCNN4MEN1POLB
SCHEMBL6740472 0.86 ITGA4 (0.43) ALDH1A1CYP2C19KMT2AATMMEN1
SCHEMBL6740469 0.86 ITGA4 (0.43) ALDH1A1CYP2C19KMT2AATMMEN1
SCHEMBL10795600 0.86 MDM4 (0.43) ALDH1A1CYP2C9THRBCYP2C19HSD17B10
SCHEMBL7890015 0.84 ELANE (0.46) NOS3NOS1NOS2CA12CA2
SCHEMBL7890011 0.84 ELANE (0.46) NOS3NOS1NOS2CA12CA2
SCHEMBL29045223 0.84 KMT2A (0.43) ALDH1A1CYP2C9THRBCYP2C19HSD17B10
SCHEMBL5799829 0.84 KMT2A (0.43) ALDH1A1CYP2C9THRBCYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326728-A1 BENZOTHIADIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS ALBIREO AB (SE) 2025-10-23 — — US disclosed
EP-4559902-A2 KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE Imago Biosciences Inc. (US) 2025-05-28 — — EP disclosed
CN-119954987-A Apoptosis bionic nano drug delivery carrier and preparation method and application thereof 暨南大学 2025-05-09 — — CN disclosed
WO-2025078654-A1 ANTIBACTERIAL COMPOUNDS VEIRULENCE LTD (GB) 2025-04-17 — — WO disclosed
CN-115867557-B Azepine condensed ring compound and medical application thereof 中国医药研究开发中心有限公司 2025-02-18 — — CN disclosed
US-12187690-B2 Benzothiadiazepine compounds and their use as bile acid modulators ALBIREO AB (SE) 2025-01-07 — — US disclosed
EP-3256218-B1 A KDM1A INHIBITOR AND ITS USE IN THERAPY IMAGO BIOSCIENCES INC (US) 2024-12-11 — — EP disclosed
CN-115038707-B Azepine condensed ring compound and medical application thereof 中国医药研究开发中心有限公司 2024-11-22 — — CN disclosed
CN-118852054-A Benzothiadiazepines cycloheptatriene compounds Compounds and their use as bile acid modulators 阿尔比里奥公司 2024-10-29 — — CN disclosed
CN-118834175-A Benzothiazacycloalkanes Heptatriene compounds use thereof as bile acid modulators 阿尔比里奥公司 2024-10-25 — — CN disclosed
US-4698231-A Sweetening with L-aminodicarboxylic acid amides GENERAL FOOD CORPORATION (US) 1987-10-06 — — US disclosed
US-4676989-A Sweetening with cycloalkyl ethers and thioethers of dipeptides GENERAL FOODS CORPORATION (US) 1987-06-30 — — US disclosed
US-4654219-A ARTIFICIAL SWEETENERS GENERAL FOODS CORPORATION (US) 1987-03-31 — — US disclosed
US-4654439-A FOOD SWEETENERS GENERAL FOODS CORPORATION (US) 1987-03-31 — — US disclosed
US-4650688-A DIPEPTIDES GENERAL FOODS CORPORATION (US) 1987-03-17 — — US disclosed
US-4638071-A ARTIFICIAL SWEETENERS GENERAL FOODS CORPORATION (US) 1987-01-20 — — US disclosed
US-4622417-A DIETETICS GENERAL FOODS CORPORATION (US) 1986-11-11 — — US disclosed
US-4622418-A LOW CALORIE SWEETENERS GENERAL FOODS CORPORATION (US) 1986-11-11 — — US disclosed
US-4603011-A ARTIFICIAL SWEETRENERS GENERAL FOODS CORPORATION (US) 1986-07-29 — — US disclosed
EP-0186173-A2 L-Aminodicarboxylic-(0-cycloalkyl)-L-aminocarboxylate alkyl esters, an edible composition containing same as sweeteners and a method for sweetening an edible composition GENERAL FOODS CORPORATION (US) 1986-07-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326728-A1 BENZOTHIADIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS SLC10A1, SLC10A2, ABCB11 ALDH1A1 580/4885CYP2C9 226/4885THRB 1413/4885
US-12187690-B2 Benzothiadiazepine compounds and their use as bile acid modulators SLC10A1, SLC10A2, ABCB11 ALDH1A1 580/4885CYP2C9 226/4885THRB 1413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.